52 Week Range
As of on the Over The Counter ∙ Minimum 15 minute delay
Oct 16 (Reuters) - Themaven Inc <MVEN.PK>::THEMAVEN INC - ON OCT 10 ANNOUNCED APPOINTMENT OF PAUL EDMONDSON AS PRESIDENT - SEC FILING.
Oct 3 (Reuters) - Themaven Inc <MVEN.PK>::THEMAVEN INC SAYS ROSS LEVINSOHN WILL SERVE AS PRESIDENT OF MMB AND CEO OF SPORTS ILLUSTRATED.
July 31 (Reuters) - TheStreet Inc <TST.O>::THESTREET PROVIDES UPDATES ON PENDING SALE TRANSACTION.SPECIAL MEETING OF STOCKHOLDERS SCHEDULED FOR AUGUST 7, 2019.INDEPENDENT PROXY ADVISORY FIRMS ISS AND GLASS LEWIS RECOMMEND STOCKHOLDERS OF THESTREET VOTE "FOR" PROPOSED MERGER WITH MAVEN.UPDATED ESTIMATES FOR PRE-MERGER DISTRIBUTION AND CONTINGENT VALUE RIGHT.CURRENTLY EXPECTS THAT ABOUT $3.7 MILLION IN FUNDS PREVIOUSLY ESCROWED REAGRDING SALE OF ITS RATEWATCH BUSINESS WILL NOW BE RELEASED ON AUG. 1.
June 17 (Reuters) - Themaven Inc <MVEN.PK>::THEMAVEN INC - ON JUNE 14, CO, UNIT OF AUTHENTIC BRANDS GROUP ENTERED LICENSING AGREEMENT TO OPERATE SPORTS ILLUSTRATED MEDIA BUSINESS.THEMAVEN INC - ROSS LEVINSOHN HAS AGREED TO BECOME NEW CEO OF LICENSED BUSINESS.THEMAVEN INC - INITIAL TERM OF LICENSING AGREEMENT SHALL COMMENCE UPON TERMINATION OF MEREDITH LICENSE AGREEMENT, CONTINUE THROUGH DEC 31, 2029.THEMAVEN INC - SHALL PAY TO ABG ANNUAL ROYALTIES IN RESPECT OF EACH YEAR OF TERM BASED ON GROSS REVENUE WITH GUARANTEED MINIMUM ANNUAL AMOUNTS.THEMAVEN INC - PREPAID ABG $45 MILLION AGAINST FUTURE ROYALTIES.THEMAVEN - PURSUING DISCUSSIONS WITH MEREDITH FOR IT TO CONTINUE TO OPERATE SOME ASPECTS OF SPORTS ILLUSTRATED MEDIA BUSINESS, INCLUDING PRINT OPERATIONS.THEMAVEN INC - LICENSING AGREEMENT IS NOT CONTINGENT ON REACHING AN AGREEMENT WITH MEREDITH.THEMAVEN - TO HAVE EXCLUSIVE RIGHT IN U.S., CANADA, MEXICO, UK, IRELAND, AUSTRALIA, NEW ZEALAND TO OPERATE SPORTS ILLUSTRATED MEDIA BUSINESS.
Integrated Surgical Systems, Inc. announced in its form 8K that effective as of June 30, 2008, David H. Adams resigned as Chief Financial Officer (CFO) of the Company. Effective as of July 2, 2008, Michael J. Tomczak was appointed as Chief Financial Officer.
Integrated Surgical Systems, Inc. announced in its Form 8 - K that Ramesh C. Trivedi has resigned as President, Chief Executive Officer, Director and Chairman of the Board of Directors of the Company.Peter B. Mills has been appointed as Chief Executive Officer and President , effective July 18, 2007.
Integrated Surgical Systems, Inc. announced that it has entered into an agreement with Novatrix Biomedical, Inc. pursuant to which Novatrix has agreed to purchase substantially all of the Comapny's assets. Novatrix is a private company located in Southern California. The principal terms of the transaction were disclosed. The Company also announced that the primary focus for the Company is to reinitiate and complete multi-center U.S. Clinical studies for the ROBODOC surgical system. The Company has secured authorization from the FDA for an additional clinical site in the U.S.A. and has received permission to restart the clinical studies. To expedite the ongoing studies even further, the Company is negotiating with an overseas hospital to conduct clinical studies following the U.S. protocol.
Integrated Surgical Systems, Inc. announces in its Form 8-k that, David H. Adams is appointed as the Chief Financial Officer of the Company in place of Charles J Novak on September 20, 2006.
Integrated Surgical Systems, Inc. announced that it has signed an agreement with FUJIFILM Medical Systems, USA to purchase certain additional technology and marketing rights for the PACS market only to those already granted under the current product development agreement. The deals of the agreement were not disclosed.
Integrated Surgical Systems, Inc. announced that it has signed an agreement with FUJIFILM Medical Systems, USA (Fuji) for the development of a 2D/3D (two/three dimensional) orthopedic surgical planning software system, which will be integrated into Fuji's Synapse System. Fuji will market it to its Synapse customers worldwide once available.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.